160646-99-1 Usage
Uses
Used in Pharmaceutical Synthesis:
DCPM is utilized as a key raw material in the production of various pharmaceuticals. Its unique structure allows it to be a valuable component in the development of new medications, contributing to the advancement of healthcare and treatment options.
Used in Agrochemical Production:
In addition to its pharmaceutical applications, DCPM is also employed as a starting material in the synthesis of agrochemicals. This use highlights its versatility and importance in the agricultural industry, where it can contribute to the development of effective pest control solutions and other related products.
Used in Organic Synthesis:
DCPM's distinctive chemical structure positions it as a promising intermediate for the synthesis of a range of organic compounds. Its role in this field is significant, as it can facilitate the creation of new chemical entities with potential applications across various industries.
Used in Anti-HIV Research:
DCPM has been studied for its potential as an anti-HIV agent. This research underscores its importance in the ongoing quest to develop effective treatments and therapies for HIV/AIDS, highlighting its potential to contribute to global health initiatives.
Safety Precautions:
It is crucial to handle DCPM with care due to its harmful nature if swallowed, inhaled, or if it comes into contact with the skin. Additionally, it may cause eye and skin irritation. Therefore, appropriate safety measures should be taken when working with this chemical to ensure the well-being of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 160646-99-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,6,4 and 6 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 160646-99:
(8*1)+(7*6)+(6*0)+(5*6)+(4*4)+(3*6)+(2*9)+(1*9)=141
141 % 10 = 1
So 160646-99-1 is a valid CAS Registry Number.
160646-99-1Relevant academic research and scientific papers
Abe, Yoshito,Kayakiri, Hiroshi,Satoh, Shigeki,Inoue, Takayuki,Sawada, Yuki,Imai, Keisuke,Inamura, Noriaki,Asano, Masayuki,Hatori, Chie,Katayama, Akira,Oku, Teruo,Tanaka, Hirokazu
, p. 564 - 578 (1998)
A novel class of potent, selective, and orally active non-peptide bradykinin (BK) B2 receptor antagonists were designed and synthesized starting from 8-benzyloxyimidazo[1,2-α]pyridine derivative 2. The unique screening lead (2) was discovered b
CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1
-
Page/Page column 69, (2008/06/13)
The present invention discloses compounds of Formula I: (I) having 11beta -HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as the use of the Fomula I and compositions as medicaments to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, Syndrome X, and other conditions associated with hyperglycemia.
IMIDAZO [1,2-A] PYRIDINES AND THEIR PHARMACEUTICAL USE
-
, (2008/06/13)
The invention relates to novel bradykinin antagonists of the formula: STR1 wherein R 1 is halogen,R 2 and R 3 are each hydrogen, lower alkyl, halo(lower)alkyl or acyl,R 4 is aryl having suitable substituent(s), or a heterocyclic group optionally having suitable substituent(s),Q is O or N--R 11, in which R 11 is hydrogen or acyl, andA is lower alkylene,and pharmaceutically acceptable salts thereof.
